<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is a disorder of <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> and pregnancy losses associated with production of anticardiolipin antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positivity </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, we have adapted a mouse model of induced <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> to study the role of autoantibodies in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="2" pm="."><plain>To determine whether immunoglobulins from patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> play a role in <z:mp ids='MP_0005048'>thrombosis</z:mp>, we injected groups of CDI mice either with immunoglobulins purified from seven patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (nine preparations studied: four IgG, three IgM and two IgA) or with immunoglobulins of the same isotype from healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Seventy-two h after injection, a non-occlusive <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was induced in the femoral veins of experimental mice by a pinch injury; the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> areas as well as times of formation and disappearance of the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> were measured </plain></SENT>
<SENT sid="4" pm="."><plain>Eight of the nine <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> immunoglobulin preparations caused a significant increase in mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> area and a significant delay in mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> disappearance time as compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="5" pm="."><plain>To determine whether anticardiolipin antibodies might be involved, separate groups of mice were injected with affinity-purified IgG (n = 2) or IgM (n = 2) anticardiolipin antibodies or with <z:mpath ids='MPATH_458'>normal</z:mpath> immunoglobulins of the same isotype, and the effects on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation compared </plain></SENT>
<SENT sid="6" pm="."><plain>Mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> area and mean disappearance times were again significantly increased in <z:hpo ids='HP_0000001'>all</z:hpo> four groups injected with affinity-purified antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>This is the first study to show that anticardiolipin antibodies of IgG, IgM and IgA isotypes may play a role in <z:mp ids='MP_0005048'>thrombosis</z:mp> in vivo </plain></SENT>
</text></document>